Hwang Larn [Rocket]

Date Filed

Type

Description

05/02/2019

Hwang Larn (10% Owner) has filed a Form 3 on MATEON THERAPEUTICS INC

05/02/2019

SC 13D

Hwang Larn reports a 23% stake in Mateon Therapeutics, Inc.

04/18/2018

Hwang Larn (Chief Scientific Officer) has filed a Form 4 on Marina Biotech, Inc.

Txns:

Converted 10 convertible preferred @ $0.5, valued at $5.2
Converted 78,300 options to buy @ $0.55, valued at $43.1k
Converted convertible notes @ $5000, valued at $0

07/05/2017

Form 4 - Statement of changes in beneficial ownership of securities

02/14/2017

Form 4 - Statement of changes in beneficial ownership of securities

02/14/2017

Form 3 - Initial statement of beneficial ownership of securities